Medicare Enrolled
Dr. Rajiv Punjya, M.D.
Cardiovascular Disease · Tracy, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Punjya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Punjya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Punjya
Dr. Rajiv Punjya is a cardiovascular disease specialist in Tracy, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Punjya performed 13,141 Medicare services across 6,007 unique beneficiaries.
Between the years covered by Open Payments, Dr. Punjya received a total of $501,295 from 58 pharmaceutical and/or device companies across 1553 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Punjya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in CA
$501,295 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,141
Medicare services
Top 4% in CA for cardiovascular disease
6,007
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~692 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
2,310 | $51 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
2,051 | $133 | $200 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
1,830 | $39 | $75 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,366 | $40 | $105 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,174 | $37 | $90 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
993 | $11 | $54 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
458 | $155 | $370 |
| Heart muscle strain imaging | 358 | $31 | $65 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
304 | $45 | $70 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
187 | $20 | $70 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
187 | $734 | $1,100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
174 | $97 | $135 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
142 | $95 | $170 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
121 | $152 | $390 |
| New patient office visit, complex (60-74 min) | 95 | $147 | $275 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 94 | $417 | $525 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $97 | $160 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
86 | $57 | $212 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
81 | $191 | $570 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
79 | $43 | $175 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
77 | $20 | $238 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
77 | $223 | $610 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
74 | $4 | $12 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
70 | $67 | $115 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
64 | $39 | $175 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
63 | $26 | $57 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
62 | $16 | $30 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
56 | $13 | $34 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
54 | $138 | $260 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
51 | $10 | $20 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
50 | $11 | $25 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
47 | $1,249 | $2,300 |
| Cardiac catheterization | 42 | $198 | $416 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
32 | $371 | $795 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
28 | $138 | $380 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
26 | $6 | $10 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
25 | $21 | $40 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
25 | $111 | $270 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
24 | $10 | $23 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
16 | $64 | $169 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.9% high complexity
10.6% medium
84.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$501,295
Total received (2018-2024)
Avg $71,614/year across 7 years
Top 1% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,553
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$481,093 (96.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,398 (3.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$804 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$73,306
2023
$109,752
2022
$121,611
2021
$55,096
2020
$31,824
2019
$42,662
2018
$67,045
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$43,925
Boehringer Ingelheim Pharmaceuticals, Inc.
$8,779
Janssen Pharmaceuticals, Inc
$6,954
Lilly USA, LLC
$5,843
Merck Sharp & Dohme LLC
$4,341
CVRx, Inc.
$628
AstraZeneca Pharmaceuticals LP
$498
Bayer Healthcare Pharmaceuticals Inc.
$435
Medtronic, Inc.
$275
E.R. Squibb & Sons, L.L.C.
$252
Boston Scientific Corporation
$204
Alnylam Pharmaceuticals Inc.
$166
Novartis Pharmaceuticals Corporation
$159
Abbott Laboratories
$156
Impulse Dynamics (USA) Inc.
$129
Kiniksa Pharmaceuticals International, plc
$104
Amgen Inc.
$90
SANOFI-AVENTIS U.S. LLC
$86
PFIZER INC.
$46
Actelion Pharmaceuticals US, Inc.
$45
Baxter Healthcare
$31
Philips North America LLC
$23
United Therapeutics Corporation
$23
Corcept Therapeutics
$21
SCPHARMACEUTICALS INC.
$20
ATRICURE, INC.
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Esperion Therapeutics, Inc.
$18
Lexicon Pharmaceuticals, Inc.
$18
Top 3 companies account for 81.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$173,616
Boehringer Ingelheim Pharmaceuticals, Inc.
$52,224
Amarin Pharma Inc.
$47,477
Janssen Pharmaceuticals, Inc
$46,332
AstraZeneca Pharmaceuticals LP
$37,933
Lilly USA, LLC
$33,944
Esperion Therapeutics, Inc.
$27,295
Amgen Inc.
$24,340
Merck Sharp & Dohme LLC
$11,890
E.R. Squibb & Sons, L.L.C.
$8,085
Novartis Pharmaceuticals Corporation
$7,629
SANOFI-AVENTIS U.S. LLC
$7,491
PFIZER INC.
$7,044
Regeneron Healthcare Solutions, Inc.
$3,916
Medtronic Vascular, Inc.
$2,055
Medtronic, Inc.
$1,895
Boston Scientific Corporation
$767
Abbott Laboratories
$738
Bayer Healthcare Pharmaceuticals Inc.
$716
Bayer HealthCare Pharmaceuticals Inc.
$673
Actelion Pharmaceuticals US, Inc.
$656
CVRx, Inc.
$628
Alnylam Pharmaceuticals Inc.
$439
BIOTRONIK INC.
$428
Kowa Pharmaceuticals America, Inc.
$315
ATRICURE, INC.
$277
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$266
Nevro Corp.
$204
Gilead Sciences, Inc.
$201
Merck Sharp & Dohme Corporation
$200
Impulse Dynamics (USA) Inc.
$129
Edwards Lifesciences Corporation
$127
GlaxoSmithKline, LLC.
$125
Teva Pharmaceuticals USA, Inc.
$125
Kiniksa Pharmaceuticals, Ltd.
$111
Kiniksa Pharmaceuticals International, plc
$104
Lexicon Pharmaceuticals, Inc.
$80
Relypsa, Inc.
$72
Nuvectra Corporation
$72
CathWorks, Inc.
$71
SCPHARMACEUTICALS INC.
$67
United Therapeutics Corporation
$59
ARBOR PHARMACEUTICALS, INC.
$57
Vifor Pharma, Inc.
$48
Sunovion Pharmaceuticals Inc.
$44
Allergan Inc.
$39
ACIST MEDICAL SYSTEMS, INC.
$38
Tactile Systems Technology Inc
$38
Baxter Healthcare
$31
BOSTON SCIENTIFIC CORPORATION
$31
PORTOLA PHARMACEUTICALS, INC.
$26
Philips North America LLC
$23
AtriCure, Inc.
$22
Corcept Therapeutics
$21
Astellas Pharma US Inc
$17
Terumo Medical Corporation
$15
Bardy Diagnostics, Inc.
$14
Noden Pharma USA Inc
$13
Top 3 companies account for 54.5% of all-time payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · AMVUTTRA · ANDEXXA · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · Adempas · Algovita · Arcalyst · Assurity Pacemaker · Attain · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CINQAIR · CONFIRM RX · CVI SYSTEMS · CardioMEMS HF System · Carnation Ambulatory Monitor · ClosureFast · Confirm Rx · Corlanor · ELIQUIS · ELUVIA · EMBLEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FFRANGIO · FLEXITOUCH · FUROSCIX · GALLANT · GENERAL BRADY · General - Brady · General - Tachy · General - Therapies · General - Vascular Intervention · Hillrom - Carnation Ambulatory Monitor · INSPIRIS RESILIA aortic valve · INVOKANA · Inpefa · JARDIANCE · JOT DX · Kerendia · Korlym · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LOKELMA · LONHALA MAGNAIR · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · MOUNJARO · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NUCALA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · RXI CONSUMABLES · RXI SYSTEMS · RYBELSUS · Ranger · Repatha · Rivacor 7 DR-T · Rybelsus · Senza · TEKTURNA · TOUJEO · TRULICITY · TYVASO · Tresiba · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · Verquvo · Victoza · WAINUA · WATCHMAN · WINREVAIR · Wegovy · XARELTO · XIGDUO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
49
Per 100K population
6.2
County median income
$88,531
Nearest hospital
SUTTER TRACY COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Punjya is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Punjya experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Punjya performed 2,310 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Punjya receive payments from pharmaceutical companies?
Yes. Dr. Punjya received a total of $501,295 from 58 companies across 1,553 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Punjya's costs compare to other cardiologists in Tracy?
Dr. Punjya's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Punjya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Tracy
Browse cardiologists in Tracy ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology